pharmaceuticals

The agency may soon approve another drug for a deadly neurodegenerative disease based on partial data that’s being debated by experts.

Drug manufacturers invested in Russia’s pharmaceutical industry contend international humanitarian law requires they continue manufacturing and selling their products there, even while condemning the Ukraine invasion.

An epic battle is playing out behind the scenes over whether the government should pay for Aduhelm, an FDA-approved Alzheimer’s drug that scientists say has not been proven to work.

Just 18% of 5- to 11-year-olds are fully vaccinated, with rates varying significantly across the country, a KHN analysis of federal data shows. Pediatricians say the slow pace and geographic disparities are alarming.

With opioid overdoses surging, harm-reduction groups are calling on the FDA to change naloxone's prescription-only status. This would make it easier to get the lifesaving drug to people at risk.

The promising antiviral drugs to treat COVID can halt hospitalizations and deaths, but only if they’re given to patients within three to five days of their first symptoms, a narrow window many people won’t meet. Here’s why.

The number of pharmacies dispensing 340B discounted drugs soared to more than 31,000 this year. Drugmakers struck back by halting some discounts. Hospitals say they are losing millions of dollars — and cutting back services to patients — as a result.

The pharmaceutical and medical device business will keep the J&J name while the division that sells Band-Aids and Listerine will go it alone.

A West Virginia pharmacist wanted to help those hit by the opioid crisis. But a few years after he began providing medications to treat addiction, drug enforcement raided his pharmacy.

Democrats agreed to a significant — but slimmed down — proposal to help lower prescription drug prices, bringing aboard notable holdouts on the measure, including Arizona Sen. Kyrsten Sinema.